GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) » Definitions » Short Interest

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Short Interest


View and export this data going back to 2021. Start your Free Trial

What is Hubei Biocause Heilen Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Hubei Biocause Heilen Pharmaceutical Co's Short Interest

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Biocause Heilen Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Biocause Heilen Pharmaceutical Co's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Biocause Heilen Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Hubei Biocause Heilen Pharmaceutical Co's Short Interest falls into.



Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Business Description

Traded in Other Exchanges
N/A
Address
No. 122, Yangwan Road, Dadao District, Jingmen High-tech Zone, Hubei Province, Jingmen, CHN, 448000
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Headlines

No Headlines